Group One Trading, L.P. Cellectis S.A. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.41 - $3.09 $2,875 - $3,686	1,193 Added 361.52%	1,523 $4,000
Q4 2023 Feb 14, 2024	BUY	$0.97 - $3.55 $320 - $1,171	330 New	330 $1,000
Q4 2020 Feb 10, 2021	SELL	$15.87 - $31.64 $3,174 - $6,328	-200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.21 - $21.02 $1,642 - $4,204	200 New	200 $4,000
Q3 2018 Nov 08, 2018	SELL	$25.99 - $30.6 $155,810 - $183,447	-5,995 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $166,541 - $230,987	5,995 New	5,995 $170,000

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.